From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. News in Context

Cardiology: News in Context

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.


to
Items 1-10 of 17 are shown

International Cardiology Societies Collaborate on New MI Definition

A task force sets clear and widely applicable criteria for diagnosis and describes specific types of MI.

  • By Allan S. Jaffe, MD
  • August 28, 2012

Renewed Warning About Combining Simvastatin and Amiodarone

  • Cardiology
  • News in Context
  • Subscription Required

The FDA issued a reminder about heightened risk for rhabdomyolysis with this combination but provided few details to assist in clinical decision making.

An Official Call to Improve Bystander Response to Sudden Cardiac Arrest

The AHA Emergency Cardiovascular Care Committee urges compression-only CPR for all bystander-witnessed cardiac arrests.

Glucose-Control Arm of ACCORD Trial Halted Early

Increased mortality associated with aggressive glucose reduction raises safety concerns.

ICD Lead Recall Frightens Patients and Physicians Alike

Medtronic’s Sprint Fidelis ICD lead has been recalled because of concerns about its long-term performance.

Manufacturer Recalls Troponin I Assay

The FDA and Abbott Laboratories have announced a recall of the company’s ARCHITECT STAT Troponin-I immunoassay, used to measure troponin I levels for the diagnosis . . .

  • June 13, 2007

FDA Asks for Black-Box Warning on Heart Failure Risk with Glitazones

In congressional testimony on June 6, 2007, the FDA commissioner revealed that the agency has requested that the manufacturers of rosiglitazone (Avandia) and pioglitazone (Actos) . . .

  • June 13, 2007

FDA Warns on Erythropoietin, Changes Dosing

Erythropoiesis-stimulating agents (ESAs) should be given in the lowest possible dose required to gradually increase hemoglobin “to the lowest level sufficient to avoid the need . . .

  • March 21, 2007

Cardiac Safety Alert for Users of Cancer Drug

An important notice about Gleevec, a drug used to treat chronic myeloid leukemia

  • By Frederick A. Masoudi, MD, MSPH
  • November 1, 2006

FDA Says Ibuprofen Interferes with Low-Dose Aspirin’s Antiplatelet Effect

How should clinicians respond to new FDA recommendations for people who use ibuprofen routinely and who also take immediate-release, low-dose aspirin?

  • By Harlan M. Krumholz, MD, SM
  • October 4, 2006
Items 1-10 of 17 are shown

to

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.